- Home
- OCUL vs BHC Comparison
OCUL vs BHC Comparison
Compare OCUL & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OCUL | BHC |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2014 | 1996 |
Fundamental Metrics
Financial Performance| Metric | OCUL | BHC |
|---|---|---|
| Price | $9.46 | $5.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 3 |
| Target Price | ★ $23.56 | $8.33 |
| AVG Volume (30 Days) | ★ 3.3M | 1.2M |
| Earning Date | 05-08-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | N/A | ★ 0.42 |
| Revenue | $1,990,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $7.93 | $4.61 |
| Revenue Next Year | $96.07 | N/A |
| P/E Ratio | ★ N/A | $13.19 |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $4.41 |
| 52 Week High | $16.44 | $8.69 |
Technical Indicators
Market Signals| Indicator | OCUL | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 55.05 | 51.38 |
| Support Level | $8.36 | $5.52 |
| Resistance Level | $9.86 | $5.62 |
| Average True Range (ATR) | 0.50 | 0.18 |
| MACD | 0.12 | 0.01 |
| Stochastic Oscillator | 76.51 | 52.56 |
Price Performance
Historical ComparisonAbout OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.